Omeflex Peri Emulsion For Infusion

Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin, the active ingredient in Omeflex Peri Emulsion For Infusion, is a mixture of essential and non‑essential amino acids presented as a sterile emulsion for intravenous infusion use. It is intended to support metabolic needs in patients requiring peri‑operative nutritional supplementation.

GNH USA supplies Omeflex Peri Emulsion For Infusion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Omeflex Peri Emulsion For Infusion provides nutritional support through amino acid supplementation for patients in peri‑operative and critical care settings. - Peri‑operative nutrition: Helps maintain nitrogen balance and supports tissue repair during the surgical period. - Critical illness: Contributes to protein synthesis and energy provision in patients with high metabolic demand. - Trauma recovery: Assists in rebuilding lean body mass after severe injury. - Burn care: Supplies essential amino acids needed for wound healing and catabolism reduction. - Long‑term parenteral nutrition: Forms part of a balanced amino‑acid regimen for patients requiring extended intravenous nutrition.

Amino‑acid emulsions are generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Mild fever or chills: transient rise in body temperature after infusion. - Local irritation: redness or discomfort at the infusion site. - Nausea: occasional feeling of queasiness during or after administration. - Headache: mild headache reported by some patients. - Hyperglycaemia: temporary increase in blood glucose levels. - Electrolyte shift: minor changes in serum electrolytes.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical intervention. - Sepsis: infection related to the infusion line or product contamination. - Metabolic acidosis: significant acid‑base disturbance. - Hepatic dysfunction: abnormal liver enzyme elevations. - Thromboembolic events: clot formation associated with intravenous therapy. - Severe hypertriglyceridemia: marked rise in blood triglyceride levels.

When using Omeflex Peri Emulsion For Infusion, clinicians should consider several safety measures. - Patient assessment: evaluate nutritional status and metabolic needs before initiation. - Monitoring: check blood glucose, electrolytes, and liver function regularly during therapy. - Compatibility: verify compatibility with other intravenous solutions and medications. - Infusion rate: administer at the recommended rate to avoid overload and metabolic complications. - Contraindications: avoid in patients with known hypersensitivity to any amino‑acid component. - Store at ambient temperature: keep in original container, protect from light and moisture.

Amino‑acid emulsions can interact with certain drugs and clinical conditions.

Major Interactions (Avoid): - High‑dose insulin therapy: may exacerbate hypoglycaemia when combined with amino‑acid infusion. - Certain antibiotics (e.g., aminoglycosides): risk of reduced efficacy due to chelation.

Moderate Interactions (Monitor Closely): - Loop diuretics: may increase electrolyte loss, requiring closer monitoring. - Corticosteroids: can amplify protein catabolism, affecting the intended nutritional benefit. - Lipid‑containing parenteral solutions: may alter triglyceride levels when co‑administered. - Renal impairment: reduced clearance of amino acids may necessitate dose adjustment. - Hepatic dysfunction: impaired metabolism may increase risk of accumulation.